Mounjaro (Tirzepatide) in South Africa: Availability, Cost and What You Need to Know in 2026

If you follow weight loss news you have almost certainly heard about Mounjaro. The injectable medication, known generically as tirzepatide, has generated enormous interest worldwide after clinical trials showed it could help people lose more than 20% of their body weight — outperforming even Ozempic (semaglutide) in head-to-head comparisons.

South Africans are understandably keen to find out whether Mounjaro is available here, what it costs in rand, and whether it might be the right option for them. This guide covers everything we know as of mid-2026, written in plain language with no hype. As always, speak to your doctor before starting any medication.

What Is Mounjaro (Tirzepatide)?

Mounjaro is the brand name for tirzepatide, manufactured by Eli Lilly. It belongs to a class of medications called incretin mimetics — the same family as Ozempic and Wegovy. But there is one key difference: while Ozempic targets a single hormone receptor (GLP-1), tirzepatide targets two — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).

This dual-action mechanism is what researchers believe gives tirzepatide its edge. In the SURMOUNT-1 clinical trial, participants on the highest dose (15 mg) lost an average of 22.5% of their body weight over 72 weeks. That is roughly a quarter of starting body weight — a result that was previously only achievable through bariatric surgery.

Mounjaro is approved internationally for type 2 diabetes. A separate brand, Zepbound, uses the same tirzepatide molecule and is approved specifically for weight management in the United States.

Is Mounjaro Available in South Africa?

This is the question most South Africans want answered, so let's be direct: Mounjaro does not yet have full SAHPRA (South African Health Products Regulatory Authority) registration for general prescription as of mid-2026.

However, that does not mean it is completely inaccessible. There are currently two routes South African patients use to access tirzepatide:

• Section 21 application: SAHPRA allows doctors to apply for access to unregistered medicines on a named-patient basis. Your doctor submits the application, providing clinical justification for why you need tirzepatide specifically. If approved, the medication can be imported and prescribed to you directly. This is the most common legal route.
• Private import channels: Some specialist weight-loss clinics and pharmacies facilitate imports through licensed pharmaceutical distributors. Availability can be inconsistent and pricing varies.

How Much Does Mounjaro Cost in South Africa?

Because tirzepatide is not yet locally registered, there is no official Single Exit Price (SEP) set by the Department of Health. What patients are paying depends on the import route, dose and supplier.

Based on reports from patients and clinics, expect costs in the range of:

These are estimates and can fluctuate with the rand exchange rate and supplier availability. Most medical aid schemes do not currently cover tirzepatide as it lacks SAHPRA registration, though some schemes may cover it under chronic benefits for type 2 diabetes if your doctor motivates. Always check with your scheme directly.

By comparison, Ozempic — which does have SAHPRA registration — costs roughly R2,500 to R3,500 per month through local pharmacies and is more likely to receive medical aid cover.

Mounjaro vs Ozempic: How Do They Compare?

This is the comparison everyone wants to see. Both are weekly injections in the same drug class, but they are not identical.

The headline is clear: tirzepatide produced greater weight loss in clinical trials. But in South Africa right now, Ozempic is easier to access, cheaper, and more likely to be covered by your medical aid. For many South Africans, Ozempic remains the more practical choice until Mounjaro receives full SAHPRA registration and local pricing is established.

Side Effects of Tirzepatide

The side effect profile is similar to other GLP-1 medications. The most commonly reported effects in clinical trials include:

• Nausea — the most frequent side effect, especially during dose escalation
• Diarrhoea and constipation
• Vomiting — usually improves after the first few weeks
• Reduced appetite — this is part of how the medication works
• Injection site reactions — mild redness or itching

More serious but less common risks include:

• Pancreatitis — seek immediate medical attention for severe, persistent abdominal pain
• Gallbladder problems — rapid weight loss can increase gallstone risk
• Thyroid tumours — observed in animal studies; tirzepatide carries a boxed warning and is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Who Qualifies for Mounjaro?

International prescribing guidelines (based on FDA and EMA approvals) generally indicate tirzepatide for:

• Type 2 diabetes — as Mounjaro, to improve blood sugar control
• Weight management — as Zepbound, for adults with a BMI of 30+ (obese), or BMI 27+ (overweight) with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea

In South Africa, since access is via Section 21, eligibility ultimately depends on your doctor's clinical judgement and SAHPRA's approval of the individual application. People who should not use tirzepatide include:

• Anyone with a personal or family history of medullary thyroid carcinoma or MEN2
• Pregnant or breastfeeding women
• People with a history of severe pancreatitis
• People with known hypersensitivity to tirzepatide

What About Diet and Exercise While on Mounjaro?

Tirzepatide is not a magic injection. The clinical trials that produced those impressive weight loss numbers all included lifestyle interventions — participants followed a reduced-calorie diet and increased their physical activity. The medication makes it easier to eat less because it reduces hunger and slows gastric emptying, but the fundamentals still matter.

For South Africans on tirzepatide, practical dietary approaches that work well alongside GLP-1 medications include:

• Protein-first meals: Aim for lean protein at every meal — chicken, fish, eggs, lean biltong, beans, lentils. Protein helps preserve muscle mass during rapid weight loss and keeps you fuller for longer.
• Smaller, more frequent meals: GLP-1 medications slow your stomach emptying. Eating smaller portions spread across the day reduces nausea and discomfort.
• Hydration: Dehydration is common, especially with gastrointestinal side effects. Keep a water bottle handy. Rooibos tea (naturally caffeine-free) is a great local option for staying hydrated without adding sugar or calories.
• Walking: The simplest, most joint-friendly exercise — especially while your body adapts to the medication. Even 30 minutes of brisk walking daily makes a measurable difference.

When Will Mounjaro Be Fully Available in South Africa?

We do not have a confirmed date. SAHPRA's registration process can take time, and Eli Lilly has not publicly announced a timeline for South African registration. However, the global demand for tirzepatide is enormous and the company is expanding manufacturing capacity and regulatory submissions worldwide.

What we can say: given the trajectory of GLP-1 medications in South Africa (Ozempic went from niche to mainstream within a few years), it is reasonable to expect broader local availability in the next one to two years. When SAHPRA registration does happen, it should bring a regulated Single Exit Price, pharmacy availability, and potential medical aid coverage — all of which will make the medication more accessible and affordable.

Key Takeaways